Core Viewpoint - Cuprina Holdings has received a noncompliance notice from Nasdaq due to its closing bid price falling below the required minimum of $1 per share for 30 consecutive business days [1]. Compliance and Listing Requirements - The company has a compliance period of 180 calendar days to regain compliance with Nasdaq's minimum bid price requirement [2]. - If the closing bid price reaches at least $1 for ten consecutive business days during this period, Nasdaq will confirm compliance and close the matter [2]. - Should the company fail to regain compliance, it may qualify for an additional 180-day period by meeting other listing requirements, potentially including a reverse stock split [3]. Current Trading Status - The notification does not result in immediate delisting, and Cuprina's shares will continue to trade under the symbol "CUPR" [4]. - The company is actively evaluating options to regain compliance and is committed to meeting Nasdaq's continued listing requirements [4]. Company Overview - Cuprina Holdings is a Singapore-based biomedical company focused on developing products for chronic wounds, infertility, and cosmeceuticals [5].
Cuprina Holdings (Cayman) Limited Announces Receipt of Nasdaq Notification Letter Regarding Minimum Bid Price Deficiency